Latest Retail News

Woolworths Group Limited has announced a fully franked ordinary dividend of AUD 0.45 per share for the six months ending June 2025, payable in September with an optional dividend reinvestment plan.

Woolworths Group posted a modest 1.7% revenue increase to $69.1 billion for the 52 weeks ending June 2025, while earnings before interest and tax (EBIT) fell 12.6%, weighed down by challenges in its Australian Food and BIG W segments.

Vonex Limited reported a significantly reduced net loss for FY25 alongside a strengthened balance sheet, operational upgrades, and a pending acquisition by Maxo Telecommunications. The company is navigating going concern uncertainties while advancing network expansion and governance reforms.

Lovisa Holdings Limited reported a 14.2% revenue increase to A$798.1 million for FY25, driven by a net addition of 131 stores globally. Profit after tax rose 4.8% to A$86.3 million, while the company declared a final unfranked dividend of 27 cents per share.

Ashley Services Group reported a 60% jump in net profit for FY25 despite a 7.3% revenue decline, focusing on debt reduction and operational efficiency to fuel future growth.

Ashley Services Group reported a 7.3% revenue decline to $515.9 million in FY25 but achieved a 60.9% rise in net profit after tax to $2.17 million, driven by operational stabilisation and strategic contract wins.

Sigma Healthcare reports a robust FY25 performance post-merger with Chemist Warehouse Group, delivering strong revenue growth and upgraded synergy targets. The company signals continued expansion and efficiency gains heading into FY26.

Sigma Healthcare reports a robust 41% rise in EBIT following its merger with Chemist Warehouse, upgrading synergy targets and expanding its retail footprint internationally.

Sigma Healthcare has completed a reverse acquisition merger with Chemist Warehouse, reporting $6 billion in revenue and declaring a fully franked dividend. The merger reshapes Australia’s pharmacy landscape with ambitious synergy targets and operational shifts.

ParagonCare Limited reported a solid FY25 with $3.6 billion in revenue and $95.2 million underlying EBITDA, marking progress in its integration and growth strategy across Asia Pacific. The company is poised for further profitability improvements and expansion in FY26.

Paragon Care Limited reported a robust 22% increase in revenue to $3.61 billion for FY25, driven by organic growth and key acquisitions including CH2 Holdings and Oborne Health Supplies. The company also refinanced its debt facilities and expanded into the dental market post-year-end.

MyEco Group reported a 9% increase in FY25 sales driven by an 82% jump in MyEco branded products, alongside a strategic operational restructure aimed at cutting costs and boosting supply chain flexibility.